Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]FORUM Pharmaceuticals Inc"
Count: 19
Selected: 0
| NCT ID | Title |
|---|
| NCT01716975 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | ||
| NCT01714661 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | ||
| NCT02246075 | Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine | ||
| NCT02004392 | Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025 | ||
| NCT01969136 | Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease | ||
| NCT01969123 | Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease | ||
| NCT01714713 | A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | ||
| NCT02149160 | Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation | ||
| NCT01487135 | Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects | ||
| NCT01984723 | EVP-6124 Renal Impairment Study | ||
| NCT01073228 | Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease | ||
| NCT01984736 | EVP-6124 Hepatic Impairment Study | ||
| NCT02037074 | Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics | ||
| NCT02001389 | Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308 | ||
| NCT00968851 | Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia | ||
| NCT01661673 | Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease | ||
| NCT01556763 | Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia | ||
| NCT00766363 | Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease | ||
| NCT01480232 | A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence |
